Insights into the neurodegenerative process of Alzheimer's disease: A role for mononuclear phagocyte-associated inflammation and neurotoxicity

Journal of Leukocyte Biology

Volumn 65, Issue 4, 1999, Pages 416-427

  Cotter, Robin L ^a,b   Burke, William J ^a   Thomas, Vince S ^a   Potter, Jane F ^a   Zheng, Jialin ^a   Gendelman, Howard E ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Central nervous system; Complement; Immunopathology; Mononuclear phagocytes; Neurotrophins; Pro inflammatory cytokines; Signal transduction; amyloid protein

Indexed keywords

AMYLOID BETA PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FAS ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; NEUROTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN DEGENERATION; BRAIN PROTECTION; CELL ACTIVATION; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; ENCEPHALITIS; GLIA CELL; HUMAN; MONONUCLEAR PHAGOCYTE; NEUROPATHOLOGY; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 0032925694     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.4.416     Document Type: Review

References (136)

1. Alzheimer, A. (1907) About a peculiar disease of the cerebral cortex. Allgemeine Zeitschrift fur Psychiatrie und Psychischt. Gerichtliche Medizin 64, 146.
2. Pendlebury, W., Solomon, P. (1996) Alzheimer's disease. Clin. Symposia 48, 1-32.
3. Evans, D., Funkenstein, H., Albert, M., et al. (1989) Prevalence of Alzheimer's disease in a community population higher than previously reported. J. Am. Med. Assoc. 262, 2551-2556.
4. Roses, A. (1994) The Alzheimer diseases. In Current Neurology (S. Appel, ed.) Chicago: Mosby-Year Book, 111.
5. Goate, A., Chartier-Harlin, M., Mullan, M., Brown, J., Crawford, F., Findani, L., Giuffra, L., Haynes, A., Irving, N., James, L. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
6. Sherrington, R., Rogaeva, E., Liang, Y., Rogaeva, E., Levesque, G., Ikeda, M., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Foncin, J., bruni, A., Montesi, M., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R., Wasco, W., Silva, H.D., Hanines, J., Pericak-Vance, M., Tanzi, R., Roses, A., Fraser, P., Rommens, J., St. George-Hyslop, P. (1995) Cloning of a gene bearing missense mutations in early-onset-familial Alzheimer's disease. Nature 375, 754-760.
7. Levy-Lahad, E., Wasco, W., Poorkaj, P., Ramano, D., Oshima, J., Pettingell, W., Yu, C., Jondro, P., Schmidt, S., Wang, K., Crowley, A., Fu, Y., Guenette, S., Galas, D., Nemens, E., Wijsman, E., Bird, T., Schellenber, G., Tanzi, R. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
8. Guo, Q., Sopher, B., Furukawa, K., Pham, D., Robinson, N., Martin, G., Mattson, M. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci 17, 4212-4222.
9. Mattson, M., Guo, Q., Furukawa, K., Pedersen, W. (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70, 1-14.
10. Lendon, C., Goate, A. (1998) Genetic factors in the etiology of Alzheimer's disease. Mediguide Geriatric Neurol. 2, 1-8.
11. Saunders, A., Strittmatter, W., Schmechel, D., George-Hiplop, P. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
12. Pericak-Vance, M., Bebout, J., Gaskell, P., Yamaoka, L., Hung, W., Alberts, M., Walker, A., Bartlett, R., Hanes, C., Welsh, K., Earl, N., Heyman, A., Clark, C., Roses, A. (1991) Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48, 1034-1050.
13. Roses, A. (1997) Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol. Dis. 4, 170-185.
14. Stern, Y., Gurland, B., Tatemichi, T., Tang, M., Wilder, D., Mayeux, R. (1994) Influence of education and occupation on the incidence of dementia. J. Am. Med. Assoc. 271, 1004-1010.
15. Jorm, A., Duijun, C. V., Fratiglioni, L., Graves, A., Heyman, A., Kokmen, E., Kondo, K., Mortimer, J., Rocca, W., Shala, S., Sonininen, H., Hofman, A. (1991) Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20, 43-47.
16. Rocca, W., Duijun, C. V., Fratiglioni, L., Graves, A., Heyman, A., Jorm, A., Kokmen, E., Kondo, K., Mortimer, J., Shala, S., Sonininen, H., Hofman, A. (1991) Maternal age and Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20, 21-27.
17. Mayeux, R., Ottman, R., Tang, M., Noboa-Bauza, L., Marder, K., Gurland, B., Stern, Y. (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501.
18. Jacob, D., Tang, M., Stern, Y., San, M., Marder, K., Bell, K., Schofield, P., Dooneief, G., Garland, B., Mayeux, R. (1998) Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50, 368-373.
19. Breitner, J. (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 17, 789-794.
20. McGeer, P., Schulzer, M., McGeer, E. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-432.
21. Stewart, W., Kawas, C., Corrada, M., Metter, E. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632.
22. Markesbery, W., Mira, S. (1996) The neuropathology of Alzheimer's disease: Diagnostic features and standardization. In Alzheimer's Disease-Cause(s). Diagnosis, Treatment, and Care (Z. Khachaturian and T. Radebaugh, eds.), New York: CRC Press, 111-123.
23. Sheng, J., Mrak, R., Griffin, W. (1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. Berlin 94, 1-5.
24. Haga, S., Akai, K., Ishii, T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. Acta Neuropathol. 77, 569-575.
25. Klegeris, A., Walker, D., McGeer, P. (1994) Activation of macrophages by Alzheimer beta-amyloid peptide. Biochem. Biophys. Res. Commun. 199, 984-991.
26. Yan, S., Chen, X., Fu, J., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., Schmidt, A. (1996) RAGE and amyloid-B peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
27. Paresce, D., Ghoush, R., Maxfield, F. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta protein via a scavenger receptor. Neuron 17, 553-565.
28. Giulian, D., Haverkamp, L., Li, J., Karshin, W. (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119-137.
29. Chen, S., Frederickson, R., Brunden, K. (1996) Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol. Aging 17, 781-787.
30. Breitner, J., Welsh, K., Helms, M., Gaskell, P., Gau, B., Roses, A., Pericak-Vance, M., Saunders, A. (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523-530.
31. Mackenzie, I., Kay, K., Munoz, D. (1995) The effect of anti-inflammatory drugs on senile plaque formation. J. Neuropathol. Exp. Neurol. 54, 427.
32. Vane, J., Botting, R. (1998) Mechanism of action of antiinflammatory drugs. Int. J. Tissue React. 20, 3-15.
33. Mackenzie, I., Munoz, D. (1998) Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50, 986-990.
34. Rogers, J., Kirby, L., Hempelman, S., Berry, D., McGeer, P., Kaszniak, A., Zalinski, J., Cofield, M., Mansukhani, L., Wilson, P., Kogan, F. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611.
35. Leu, L., Brachova, L., Civin, H., Rogers, J. (1996) Inflammation, beta-amyloid deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54.
36. Kalaria, R., Cohen, D., Premkumar, D. (1996b) Cellular aspects of the inflammatory response in Alzheimer's disease. Neurodegen. 5, 497-503.
37. Aisen, P. (1997) Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontol. 43, 143-149.
38. Itagaki, S., McGeer, P., Akiyama, H., Zhu, S., Selkoe, D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182.
39. Khachaturian, Z., Phelps, C., Buckholtz, N. (1994) The prospect of developing treatments for Alzheimer disease. In Alzheimer Disease (R. Terry, R. Katzman, and K. Bick, eds.), New York: Raven Press, 445-454.
40. Imamoto, K., Leblond, C. P. (1977) Presence of labeled monoyctes, macrophages, and microglia in a stab wound of the brain following an injection of bone marrow cells labeled with 3H-uridine into rats. J. Comp. Neurol. 174, 255-280.
41. Huitinga, I., Rooijen, N. V., Groot, C. D., Uitdehaag, M., Dijkstra, D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033.
42. Marty, S., Dusart, I., Peschanski, M. (1991) Glial changes following an excitotoxic lesion in the CNS-1. Microglia/macrophages. Neurosci. 45, 529-539.
43. Gelbard, H., Nottet, H., Dzenko, K., Jett, M., Genis, P., White, R., Wang, L., Choi, Y.-B., Zhang, D., Lipton, S., Swindells, S., Epstein, L., Gendelman, H. (1994) Platelet-activating factor: a candidate human immunodeficiency virus type-1 infection neurotoxin. J. Virol. 68, 4628-4635.
44. Nottet, H., Jett, M., Flanagan, C., Zhai, Q.-H., Persidsky, Y., Rizzino, A., Bernton, E., Genis, P., Baldwin, T., Schwartz, J., LaBenz, C., Gendelman, H. (1995) A regulatory role for astrocytes in HIV-1 encephalitis: an overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1 infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154, 3567-3581.
45. Fauci, A., Pantaleo, G., Stanley, S., Weissman, D. (1996) Immunopathogenic mechanisms of HIV infection. Ann. Internal Med. 124, 654-663.
46. Gendelman, H., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997) The neuropathogenesis of AIDS dementia complex. AIDS 11, S35-S45.
47. Williams, K., Ulvestad, E., Hickey, W. (1994a) Immunology of multiple sclerosis. Clin. Neurosci. 2, 229-245.
48. Colton, C., Gilbert, D. (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223, 284-288.
49. Banati, R., Gehrmann, J., Schubert, P., Kreutzberg, G. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
50. McGeer, P., Itagaki, M., Boyes, B., McGeer, E. (1988b) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
51. Glass, J., Fedor, H., Wesselingh, S., McArthur, J. (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlation with dementia. Ann. Neurol. 38, 755-762.
52. Barger, S., Harmon, A. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881.
53. Meda, L., Cassatella, M., Szendrei, G., Otvos, L., Baron, P., Villalba, M., Ferrari, D., Rossi, F. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
54. Goldgaber, D., Harris, H., Hla, T., Maciag, T., Donnelly, R., Jacobsen, J., Vitek, M., Gajdusek, D. (1989) IL-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
55. Schmechel, D. E., Goldgaber, D., Burkhart, D. S., Gilbert, J. R., Gajdusek, D. C., Roses, A. D. (1988) Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2, 96-111.
56. McGeer, E., McGeer, P. (1997) The role of the immune system in neurodegenerative disorders. Movement Disorders 12, 855-858.
57. McGeer, P., McGeer, E. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
58. Cacabelos, R., Alvarez, X., Fernandez-Novoa, L., Franco, A., Mangues, R., Pellicer, A., Nishimura, T. (1994) Brain interleukin-1beta in Alzheimer's disease and vascular dementia. Meth. Find. Exp. Clin. Pharmacol. 16, 141-145.
59. Dickson, D., Lee, S., Mattiace, L., Yen, S.-H., Brosnan, C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
60. Wood, J., Wood, P., Ryan, R., Graff-Radford, N., Pilapil, C., Robitaille, Y., Quirion, R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-beta or IL-IRA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
61. Benveniste, E. (1992) Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am. J. Physiol. 263, C1-C16.
62. Kolson, D., Pomerantz, R. (1996) AIDS dementia and HIV-1-induced neurotoxicity: possible pathogenic associations and mechanisms. J. Biomed. Sci. 3, 389-414.
63. Lieb, K., Fiebich, B., Schaller, H., Berger, M., Bauer, J. (1996) Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67, 2039-2044.
64. Ma, J., Yee, A., Brewer, B., Das, S., Potter, H. (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer B-protein into filaments. Nature 372, 92-94.
65. Blume, A., Vitek, M. (1989) Focusing on IL-1 promotion of beta-amyloid precursor protein synthesis as an early event in Alzheimer's disease. Neurobiol. Aging 10, 406-408.
66. Griffin, W., Sheng, J., Roberts, G., Mrak, R. (1995) Interleukin-1 expression in different plaque types in Alzheimer's diseases: Significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276-281.
67. Blasko, I., Schmitt, T., Steiner, E., Trieb, K., Grubeck-Loebenstein, B. (1997) Tumor necrosis factor alpha augments amyloid beta protein (25-35) induced apoptosis in human cells. Neurosci. Lett. 238, 17-20.
68. Chao, C., Hu, S. (1994) Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16, 172-179.
69. 2+ currents in cultured sympathetic neurons. J. Neurosci. 12, 2665-2671.
70. Chao, C., Hu, S., Erlich, L., Peterson, P. (1995d) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9, 355-365.
71. Bellinger, F., Madamba, S., Siggins, G. (1993) Interleukin-1 inhibits synaptic strength and long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181, 323-326.
72. Tancredi, V., DiArcangelo, G., Grassi, F., Tarroni, P., Palmieri, G., Santoni, A., Eusebi, F. (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 146, 176-178.
73. Persidsky, Y., Stins, M., Way, D., et al. (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158, 499-510.
74. Eikelenboom, P., Veerhuis, R. (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 17, 673-680.
75. Chao, C., Hu, S., Molitor, W., Shaskin, E., Peterson, P. (1992a) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
76. Klegeris, A., McGeer, P. (1997) β-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49, 229-235.
77. Gendelman, H., Lipton, S., Tardieu, M., Bukrinsky, M., Nottet, H. (1994) The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 56, 389-398.
78. Mallat, M., Chamak, B. (1994) Brain macrophages: neurotoxic or neurotrophic effector cells? J. Leukoc. Biol. 56, 416-422.
79. Giulian, D., Vaca, K., Corpuz, M. (1993) Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
80. Fowler, C. (1997) The role of the phosphoinositide signalling system in the pathogenesis of sporadic Alzheimer's disease: a hypothesis. Brain Res. Rev. 25, 373-380.
81. Beckman, J., Beckman, T., Chen, J., Marshall, P., Freeman, B. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
82. Dawson, V., Dawson, T., London, E., Bredt, D., Snyder, S. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
83. Bonfoco, E., Kraine, D., Ankarerona, M., Nicotera, P., Lipton, S. (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162-7166.
84. Olney, J. (1990) Excitotoxin-mediated neuron death in youth and old age. Prog. Brain Res. 86, 37-51.
85. Coyle, J., Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
86. Lafon-Cazal, M., Pietri, S., Culcasi, M., Bockaert, J. (1993) Nature (London) 364, 535-537.
87. DeBoni, U., McLachlan, D. (1985) Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons by Glu and aspartate, J. Neurol. Sci. 68, 105-118.
88. Chao, C., Hu, S., Peterson, P. (1995) Glia, cytokines, and neurotoxicity. Crit. Rev. Neurobiol. 9, 189-205.
89. Mattson, M., Rydel, R., Lieberburg, I., Smith-Swintosky, V. (1993) Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples. Ann. NY. Acad. Sci. 679, 1-21.
90. Elkabes, S., DiCicco-Bloom, E., Black, I. (1996) Brain microglia/ macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16, 2508-2521.
91. Araujo, D., Cotman, C. (1992) Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 112, 1668-1678.
92. Taylor, L., Marshak, D., Landreth, G. (1993) Identification of a nerve growth factor- and epidermal growth factor-regulated protein kinase that phosphorylates the protooncogene product c-Fos. Proc. Natl. Acad. Sci. USA 90, 368-372.
93. Fowler, C., O'Neill, C., Winblad, B., Cowburn, R. (1992) Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease. Acta Neurol. Scand. Suppl. 139, 59-62.
94. Iismaa, T., Biden, T., Shine, J. (1995) G Protein-Coupled Receptors Austin, TX: RG Landes.
95. Schubert, P., Ogata, T., Rudolphi, K., Marchini, C., McRae, A., Ferroni, S. (1997) Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. Ann. NY Acad. Sci. 826, 337-347.
96. Yao, H., York, R., Mirsa-Press, A., Carr, D., Stork, P. (1998) The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273, 8240-8247.
97. Schubert, P., Ogata, T., Marchini, C., Ferroni, S., Rudolph, K. (1997) Protective mechanisms of adenosine in neurons and glial cells. Ann. NY Acad. Sci. 825, 1-10.
98. Lee, R., Araki, W., Wurtman, R. (1997) Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation. Proc. Natl. Acad. Sci. USA 94, 5422-5426.
99. Efthimiopoulos, S., Punj, S., Manolopoulus, V., Pangalos, M., Wang, G., Refolo, L., Robakis, N. (1996) Intracellular cyclic AMP inhibits constitutive and phorbol-ester-stimulated secretory cleavage of amyloid precursor protein. J. Neurochem. 67, 872-875.
100. Kelly, J., Furukawa, K., Barger, S., Rengen, M., Mark, R., Blanc, E., Roth, G., Mattson, M. (1996) Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
101. Olds, J., Alkon, D. (1991) A role for protein kinase C in associative learning. New Biol. 3, 27-35.
102. Hung, A., Haas, C., Nitsch, R., et al. (1993) Activation of protein kinase C inhibits cellular production of the amyloid-protein. J. Biol. Chem. 268, 22959-22962.
103. Li, X., Song, L., Jope, R. (1996) Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J. Neurosci. 16, 5914-5922.
104. Jope, R., Song, L., Powers, R. (1997) Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging 18, 111-120.
105. Boyce, J., Shea, T. (1997) Phosphorylation events mediated by protein kinase C alpha and epsilon participate in regulation of tau steady-state levels and generation of certain "Alzheimer-like" phospo-epitopes. Int. J. Dev. Neurosci. 15, 295-307.
106. 3H]inositol 1, 4, 5-trisphosphate binding in Alzheimer's disease. Neurosci. Lett. 94, 198-202.
107. Saito, K., Elce, J., Hamos, J., Nixon, R. (1993) Widespread activation of calcium-activated neutral protease (calpain) in the brain in AD: a potential molecular basis of neuronal degeneration. Proc. Natl. Acad. Sci. USA 90, 2628-2632.
108. Magnusson, A., Haug, L., Walaas, S., Ostvold, A. (1993) Calcium-induced degradation of the IP3 receptor/calcium channel. FEBS Lett. 323, 229-232.
109. Hartmann, H., Eckert, A., Muller, W. (1994) Disturbances of the neuronal calcium homeostasis in the aging nervous system. Life Sci. 55, 2011-2018.
110. Landfield, P., Thibault, O., Mazzanti, M., Porter, N., Kerr, D. (1992) Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. J. Neurobiol. 23, 1247-1260.
111. Mattson, M. (1992) Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27, 29-49.
112. Eckert, A., Forstl, H., Zerfass, R., Hartmann, H., Muller, W. (1996) Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease. Life Sci. 59, 499-510.
113. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265-271.
114. Kerr, J., Harmon, B. (1991) Apoptosis: The molecular basis of cell death. In Current Communications on Cell and Molecular Biology, Volume 3, Cold Spring Harbor, NY: Cold Spring Harbor Press, 5-29.
115. Wei, H., Wei, W., Bredesen, D., Perry, D. (1998) Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J. Neurochem. 70, 2305-2314.
116. Reed, J. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
117. Cotman, C. (1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging 19, S29-S32.
118. Su, J., Satou, T., ANderson, A., Cotman, C. (1996) Upregulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease. NeuroReport 7, 437-440.
119. Kane, D., Sarafian, T., Anton, R., et al. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
120. Krajewski, S., Krajewski, M., Shabaik, A., Miyashita, T., Wang, H., Reed, J. (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145, 1323-1336.
121. Oltvai, Z., Milliman, C., Korsmeyer, S. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74, 609-619.
122. Su, J., Deng, G., Cotman, C. (1997) Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, bcl-2 expression and brain pathology. J. Neuropathol. Exp. Neurol. 56, 86-93.
123. MacGibbon, G., Lawlor, P., Sirimanne, E., Walton, M., Connor, B., Young, D., Williams, C., Gluckman, P., Faull, R., Hughes, P., Dragunow, M. (1997) Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750, 223-234.
124. De La Monte, S., Sohn, Y., Wands, J. (1997) Correlates of p53 and fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152, 73-83.
125. MacGibbon, G., Lawlor, P., Walton, M., Sirimanne, E., Faull, R., Synek, B., Mee, E., Connor, B., Dragunow, M. (1997) Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp. Neurol. 147, 316-322.
126. Gillardon, F., Skutella, T., Uhlmann, E., Holsboer, F., Zimmerman, M., Behl, C. (1996) Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity. Brain Res. 706, 169-172.
127. Mattson, M., Goodman, Y., Luo, H., Fu, W., Furukawa, K. (1997) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
128. O'Neill, L., Kaltschmidt, C. (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurol. Sci. 20, 252-258.
129. Wang, C., Mayo, M., Baldwin, A. (1996) TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappa B. Science 274, 784-787.
130. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P., Kaltschmidt, C. (1997) Transcription factor NK-kappa B is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
131. Akama, K., Albanese, C., Pestell, R., VanEldik, L. (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 5795-5800.
132. Stadelmann, C., Bruck, W., Bancher, C., Jellinger, K., Lassmann, H. (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J. Neuropathol. Exp. Neurol. 57, 456-464.
133. Bancher, C., Lassmann, H., Breitschopf, H., Jellinger, K. (1997) Mechanisms of cell death in Alzheimer's disease. J. Neural. Transm. Suppl. 50, 141-152.
134. Cotman, C., Su, J. (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6, 493-506.
135. Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M., Perry, G., Whitehouse, P., Taniguchi, T. (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780, 260-269.
136. Abate, C., Luk, D., Curran, T. (1990) Ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly. Cell Growth Diff. 1, 455-462.